Search

Search Constraints

You searched for: Author/Creator Emamekhoo, Hamid

Search Results

2. Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023. Issue 2 (23rd February 2023)

3. Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma. Issue 9 (3rd March 2021)

4. Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. Issue 6 (9th December 2021)

6. MP48-16 18F-DCFPYL PSMA PET IMAGING IMPROVES DETECTION OF NODAL METASTASES IN COMPARISON TO CONVENTIONAL IMAGING IN PATIENTS WITH LOCALLY ADVANCED OR OLIGOMETASTATIC PROSTATE CANCER. (May 2022)

7. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial. Issue 3 (March 2022)

9. Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). Issue 3 (11th March 2022)

10. Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer. (13th May 2020)